{"AllianceGenome": "9392", "HGNC": "9392", "MIM": "176912", "_id": "5577", "_version": 1, "accession": {"genomic": ["AC004492.1", "AC006387.3", "CH236947.1", "CH471070.1", "CP068271.2", "EF157730.1", "NC_000007.14", "NC_060931.1", "NW_017852930.1"], "protein": ["AAA60099.1", "AAC08318.1", "AAH75800.1", "AAS07389.1", "ABO15447.1", "BAF84130.1", "BAG54705.1", "EAL24395.1", "EAW83390.1", "EAW83391.1", "NP_002727.2", "P31323.3"], "rna": ["AK128639.1", "AK291441.1", "AL559918.3", "BC014355.1", "BC075800.1", "BQ022817.1", "CA405423.1", "CF593944.1", "M31158.1", "NM_002736.3"], "translation": [{"protein": "BAG54705.1", "rna": "AK128639.1"}, {"protein": "AAA60099.1", "rna": "M31158.1"}, {"protein": "AAH75800.1", "rna": "BC075800.1"}, {"protein": "BAF84130.1", "rna": "AK291441.1"}, {"protein": "NP_002727.2", "rna": "NM_002736.3"}]}, "alias": ["PRKAR2", "RII-BETA"], "ec": "2.7.11.1", "ensembl": {"gene": "ENSG00000005249", "protein": ["ENSP00000265717", "ENSP00000516463"], "transcript": ["ENST00000265717", "ENST00000393613", "ENST00000488792", "ENST00000706580", "ENST00000706581", "ENST00000706582", "ENST00000706583", "ENST00000706584", "ENST00000706585", "ENST00000706586", "ENST00000706587", "ENST00000706588", "ENST00000706589", "ENST00000706590", "ENST00000706591", "ENST00000706592", "ENST00000706593"], "translation": [{"protein": "ENSP00000265717", "rna": "ENST00000265717"}, {"protein": "ENSP00000516463", "rna": "ENST00000706581"}], "type_of_gene": "protein_coding"}, "entrezgene": "5577", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 15.6041187169, "exp_mis": 129.376305287, "exp_syn": 62.6547404886, "lof_z": 3.91299536639388, "mis_z": 2.76831260253334, "mu_lof": 1.07767742929e-06, "mu_mis": 1.4062101342e-05, "mu_syn": 7.15253929897e-06, "n_lof": 0.0, "n_mis": 65.0, "n_syn": 52.0, "p_li": 0.995321215882976, "p_null": 4.56112438593304e-07, "p_rec": 0.00467832800458495, "syn_z": 0.834478929789967}, "bp": 1257, "cds_end": 106800027, "cds_start": 106685352, "n_exons": 11, "nonpsych": {"exp_lof": 13.9115737579, "exp_mis": 116.8863846, "exp_syn": 56.496926427, "lof_z": 3.6630263626171, "mis_z": 2.84053397488948, "mu_lof": 1.07767742929e-06, "mu_mis": 1.4062101342e-05, "mu_syn": 7.15253929897e-06, "n_lof": 0.0, "n_mis": 56.0, "n_syn": 46.0, "p_li": 0.992328639458455, "p_null": 1.86225470778687e-06, "p_rec": 0.00766949828683745, "syn_z": 0.879252127804811}, "nontcga": {"exp_lof": 14.3351583672, "exp_mis": 119.005577923, "exp_syn": 57.6217320941, "lof_z": 3.73493047326864, "mis_z": 2.92310189316428, "mu_lof": 1.07767742929e-06, "mu_mis": 1.4062101342e-05, "mu_syn": 7.15253929897e-06, "n_lof": 0.0, "n_mis": 55.0, "n_syn": 49.0, "p_li": 0.992797574889139, "p_null": 1.30628073012785e-06, "p_rec": 0.00720111883013084, "syn_z": 0.71915673188107}, "transcript": "ENST00000265717.4"}, "exons": [{"cdsend": 5104, "cdsstart": 2503, "chr": "7_KV880765v1_fix", "position": [[2503, 2571], [2707, 2846], [4970, 7333]], "strand": 1, "transcript": "NM_002736", "txend": 7333, "txstart": 2503}, {"cdsend": 107159582, "cdsstart": 107044907, "chr": "7", "position": [[107044704, 107045214], [107070280, 107070316], [107121951, 107122004], [107128211, 107128295], [107140846, 107140953], [107146307, 107146461], [107150921, 107151023], [107153176, 107153251], [107156983, 107157049], [107157185, 107157324], [107159448, 107161811]], "strand": 1, "transcript": "NM_002736", "txend": 107161811, "txstart": 107044704}], "exons_hg19": [{"cdsend": 106800027, "cdsstart": 106685352, "chr": "7", "position": [[106685149, 106685659], [106710725, 106710761], [106762396, 106762449], [106768656, 106768740], [106781291, 106781398], [106786752, 106786906], [106791366, 106791468], [106793621, 106793696], [106797428, 106797494], [106797630, 106797769], [106799893, 106802256]], "strand": 1, "transcript": "NM_002736", "txend": 106802256, "txstart": 106685149}], "generif": [{"pubmed": 12727985, "text": "lipolytic catecholamine resistance of sc adipocytes in polycystic ovary syndrome is probably due to a combination of decreased amounts of beta(2)-adrenergic receptors, the regulatory II beta-component of protein kinase A, and hormone-sensitive lipase"}, {"pubmed": 14500661, "text": "Nuclear RII beta can act as a repressor of CREB transcriptional activity in T cells, providing a potential functional significance for aberrant levels of nuclear RII beta in systemic lupus erythematosus T cells."}, {"pubmed": 14744463, "text": "there are abnormalities in [3H]cAMP binding and catalytic activity kinase A in brain of depressed suicide victims, which could be due to reduced expression of RIIbeta and Cbeta"}, {"pubmed": 15187164, "text": "serine 114 phosphorylation and nuclear localization of RIIbeta controls the regulation of IL-2 gene expression in T cells."}, {"pubmed": 17904549, "text": "A high R1/R2 ratio favors the proliferation of well differentiated and hormone producing adrenocortical cells, while unbalanced expression of these subunits is not required for malignant transformation."}, {"pubmed": 18505904, "text": "Loss of PRKAR2B protein due to a post-transcriptional mechanism in ACA-S is a new mechanism of cAMP pathway dysregulation in adrenocortical tumorigenesis."}, {"pubmed": 18544528, "text": "PKA RII(beta) is responsible for increased glucocorticoid sensitivity, critical for cAMP-mediated synergistic cell killing in CEM cells"}, {"pubmed": 18625701, "text": "both the constitutive and cAMP-induced release of TNFR1 exosome-like vesicles occur via PKA-dependent pathways that are regulated by the anchoring of RIIbeta to BIG2 via AKAP domains B and C"}, {"pubmed": 20195266, "text": "Clinical trial and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20379146, "text": "Observational study and genome-wide association study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21068099, "text": "Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 24737441, "text": "Because of limited power, PRKAR2B's role in antipsychotic-induced weight gain is unclear, but biological evidence suggests that PRKAR2B may be involved"}, {"pubmed": 25268545, "text": "Although the depletion of PRKAR1A and PRKAR2B in adrenocortical cells has similar effects on cell proliferation and apoptosis; loss of these PKA subunits differentially affects cyclin expression."}, {"pubmed": 25477193, "text": "Leu206Arg and Leu199_Cys200insTrp mutations in PRKACA impair its association with PRKAR2B and PRKAR1A."}, {"pubmed": 26158466, "text": "Release of pRIIbeta in the presence of cAMP is reduced by calcium, whereas autophosphorylation at the phosphorylation site inhibits holoenzyme reassociation with the catalytic subunit."}, {"pubmed": 28008150, "text": "Study identified the overexpression of PRKAR2B in castration-resistant prostate cancer (CRPC) mouse models and patients, and showed it promoted CRPC cell proliferation, invasion and survival by mainly modulates cell cycle gene expression. These results provide evidence that PRKAR2B is a novel oncogenic gene in CRPC."}, {"pubmed": 28250426, "text": "In this study, the authors linked for the first time the loss of RIIbeta protein levels to the PRKACA mutation status and found the down-regulation of RIIbeta to arise post-transcriptionally."}, {"pubmed": 29761841, "text": "PRKAR2B induces epithelial-mesenchymal transition and promotes castration-resistant prostate cancers metastasis by activating the Wnt/beta-catenin signaling. PRKAR2B might be served as a potential target for castration-resistant prostate cancers therapy."}, {"pubmed": 31363049, "text": "Biochemical studies demonstrate how the removal of ATP primes the holoenzyme for cAMP-mediated activation. The opposing competition between ATP/cAMP is unique to RIalpha..Comparisons to the RIIb holoenzyme demonstrate isoform-specific holoenzyme interfaces and highlights distinct allosteric mechanisms for activation in addition to the structural diversity of the isoforms"}, {"pubmed": 31986411, "text": "Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer."}, {"pubmed": 32111982, "text": "Hypoxia and the hypoxia inducible factor 1alpha activate protein kinase A by repressing RII beta subunit transcription."}, {"pubmed": 33025691, "text": "PRKAR2B-HIF-1alpha loop promotes aerobic glycolysis and tumour growth in prostate cancer."}], "genomic_pos": {"chr": "7", "end": 107161811, "ensemblgene": "ENSG00000005249", "start": 107044705, "strand": 1}, "genomic_pos_hg19": {"chr": "7", "end": 106802256, "start": 106685094, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001932", "qualifier": "involved_in", "term": "regulation of protein phosphorylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006631", "qualifier": "involved_in", "term": "fatty acid metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007612", "qualifier": "involved_in", "term": "learning"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0035556", "pubmed": 2851102, "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050804", "qualifier": "involved_in", "term": "modulation of chemical synaptic transmission"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097332", "qualifier": "involved_in", "term": "response to antipsychotic drug"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0141162", "pubmed": 21812984, "qualifier": "involved_in", "term": "negative regulation of cAMP/PKA signal transduction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:2000480", "qualifier": "involved_in", "term": "negative regulation of cAMP-dependent protein kinase activity"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 21423175, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005813", "pubmed": 21399614, "qualifier": "located_in", "term": "centrosome"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 21423175, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005952", "qualifier": "part_of", "term": "cAMP-dependent protein kinase complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043025", "qualifier": "located_in", "term": "neuronal cell body"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0043197", "qualifier": "located_in", "term": "dendritic spine"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0043198", "qualifier": "located_in", "term": "dendritic shaft"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0048471", "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 23533145, "qualifier": "located_in", "term": "extracellular exosome"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0097546", "qualifier": "located_in", "term": "ciliary base"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098978", "qualifier": "located_in", "term": "glutamatergic synapse"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004862", "qualifier": "enables", "term": "cAMP-dependent protein kinase inhibitor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004862", "pubmed": 21812984, "qualifier": "enables", "term": "cAMP-dependent protein kinase inhibitor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [17148597, 20007971, 23455922, 24605759, 25477193, 25920809, 26496610, 26871637, 27107012, 28514442, 32296183, 32707033, 33058759], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008603", "pubmed": 21812984, "qualifier": "enables", "term": "cAMP-dependent protein kinase regulator activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0019904", "qualifier": "enables", "term": "protein domain specific binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0030552", "qualifier": "enables", "term": "cAMP binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0031625", "pubmed": 21423175, "qualifier": "enables", "term": "ubiquitin protein ligase binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0034236", "qualifier": "enables", "term": "protein kinase A catalytic subunit binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0034236", "pubmed": 21812984, "qualifier": "enables", "term": "protein kinase A catalytic subunit binding"}]}, "homologene": {"genes": [[7955, 100331387], [8364, 100495356], [9031, 769420], [9544, 700770], [9598, 744011], [9606, 5577], [9615, 475887], [9913, 282463], [10090, 19088], [10116, 24679]], "id": 37666}, "interpro": [{"desc": "Cyclic nucleotide-binding domain", "id": "IPR000595", "short_desc": "cNMP-bd_dom"}, {"desc": "cAMP-dependent protein kinase regulatory subunit", "id": "IPR012198", "short_desc": "cAMP_dep_PK_reg_su"}, {"desc": "RmlC-like jelly roll fold", "id": "IPR014710", "short_desc": "RmlC-like_jellyroll"}, {"desc": "Cyclic nucleotide-binding, conserved site", "id": "IPR018488", "short_desc": "cNMP-bd_CS"}, {"desc": "Cyclic nucleotide-binding domain superfamily", "id": "IPR018490", "short_desc": "cNMP-bd_dom_sf"}, {"desc": "cAMP-dependent protein kinase regulatory subunit, dimerization-anchoring domain", "id": "IPR003117", "short_desc": "cAMP_dep_PK_reg_su_I/II_a/b"}], "ipi": ["IPI00554752", "IPI01009627"], "map_location": "7q22.3", "name": "protein kinase cAMP-dependent type II regulatory subunit beta", "other_names": ["H_RG363E19.2", "WUGSC:H_RG363E19.2", "cAMP-dependent protein kinase type II-beta regulatory chain", "cAMP-dependent protein kinase type II-beta regulatory subunit", "protein kinase, cAMP-dependent, regulatory subunit type II beta", "protein kinase, cAMP-dependent, regulatory, type II, beta"], "pantherdb": {"HGNC": "9392", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "97760", "ortholog_type": "LDO", "panther_family": "PTHR11635", "taxid": 10090, "uniprot_kb": "P31324"}, {"RGD": "3394", "ortholog_type": "LDO", "panther_family": "PTHR11635", "taxid": 10116, "uniprot_kb": "P12369"}, {"Ensembl": "ENSGALG00000008060", "ortholog_type": "LDO", "panther_family": "PTHR11635", "taxid": 9031, "uniprot_kb": "F1NC65"}, {"Ensembl": "ENSDARG00000036446", "ortholog_type": "LDO", "panther_family": "PTHR11635", "taxid": 7955, "uniprot_kb": "A0A2R8QQ34"}, {"FlyBase": "FBgn0022382", "ortholog_type": "LDO", "panther_family": "PTHR11635", "taxid": 7227, "uniprot_kb": "P81900"}, {"SGD": "S000001295", "ortholog_type": "LDO", "panther_family": "PTHR11635", "taxid": 4932, "uniprot_kb": "P07278"}, {"PomBase": "SPAC8C9.03", "ortholog_type": "LDO", "panther_family": "PTHR11635", "taxid": 4896, "uniprot_kb": "P36600"}], "uniprot_kb": "P31323"}, "pathway": {"biocarta": [{"id": "agpcrpathway", "name": "attenuation of gpcr signaling"}, {"id": "akap13pathway", "name": "rho-selective guanine exchange factor akap13 mediates stress fiber formation"}, {"id": "akap95pathway", "name": "akap95 role in mitosis and chromosome dynamics"}, {"id": "akapcentrosomepathway", "name": "protein kinase a at the centrosome"}, {"id": "badpathway", "name": "regulation of bad phosphorylation"}, {"id": "carm1pathway", "name": "transcription regulation by methyltransferase of carm1"}, {"id": "cftrpathway", "name": "cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway"}, {"id": "chrebppathway", "name": "chrebp regulation by carbohydrates and camp"}, {"id": "ck1pathway", "name": "regulation of ck1/cdk5 by type 1 glutamate receptors"}, {"id": "crebpathway", "name": "transcription factor creb and its extracellular signals"}, {"id": "cskpathway", "name": "activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor"}, {"id": "dreampathway", "name": "repression of pain sensation by the transcriptional regulator dream"}, {"id": "gata3pathway", "name": "gata3 participate in activating the th2 cytokine genes expression"}, {"id": "gpcrpathway", "name": "signaling pathway from g-protein families"}, {"id": "gspathway", "name": "activation of camp-dependent protein kinase pka"}, {"id": "mcalpainpathway", "name": "mcalpain and friends in cell motility"}, {"id": "mprpathway", "name": "how progesterone initiates the oocyte maturation"}, {"id": "no1pathway", "name": "actions of nitric oxide in the heart"}, {"id": "nos1pathway", "name": "nitric oxide signaling pathway"}, {"id": "plcepathway", "name": "phospholipase c-epsilon pathway"}, {"id": "pparapathway", "name": "mechanism of gene regulation by peroxisome proliferators via ppara"}, {"id": "stathminpathway", "name": "stathmin and breast cancer resistance to antimicrotubule agents"}], "kegg": {"id": "hsa04910", "name": "Insulin signaling pathway - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-109582", "name": "Hemostasis"}, {"id": "R-HSA-111885", "name": "Opioid Signalling"}, {"id": "R-HSA-111931", "name": "PKA-mediated phosphorylation of CREB"}, {"id": "R-HSA-111933", "name": "Calmodulin induced events"}, {"id": "R-HSA-111996", "name": "Ca-dependent events"}, {"id": "R-HSA-111997", "name": "CaM pathway"}, {"id": "R-HSA-112040", "name": "G-protein mediated events"}, {"id": "R-HSA-112043", "name": "PLC beta mediated events"}, {"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1489509", "name": "DAG and IP3 signaling"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-163359", "name": "Glucagon signaling in metabolic regulation"}, {"id": "R-HSA-163615", "name": "PKA activation"}, {"id": "R-HSA-163685", "name": "Integration of energy metabolism"}, {"id": "R-HSA-163685", "name": "Integration of energy metabolism"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-164378", "name": "PKA activation in glucagon signalling"}, {"id": "R-HSA-180024", "name": "DARPP-32 events"}, {"id": "R-HSA-1852241", "name": "Organelle biogenesis and maintenance"}, {"id": "R-HSA-2565942", "name": "Regulation of PLK1 Activity at G2/M Transition"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-380259", "name": "Loss of Nlp from mitotic centrosomes"}, {"id": "R-HSA-380270", "name": "Recruitment of mitotic centrosome proteins and complexes"}, {"id": "R-HSA-380284", "name": "Loss of proteins required for interphase microtubule organization from the centrosome"}, {"id": "R-HSA-380287", "name": "Centrosome maturation"}, {"id": "R-HSA-380320", "name": "Recruitment of NuMA to mitotic centrosomes"}, {"id": "R-HSA-381676", "name": "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-418555", "name": "G alpha (s) signalling events"}, {"id": "R-HSA-418594", "name": "G alpha (i) signalling events"}, {"id": "R-HSA-422356", "name": "Regulation of insulin secretion"}, {"id": "R-HSA-432040", "name": "Vasopressin regulates renal water homeostasis via Aquaporins"}, {"id": "R-HSA-438064", "name": "Post NMDA receptor activation events"}, {"id": "R-HSA-442720", "name": "CREB1 phosphorylation through the activation of Adenylate Cyclase"}, {"id": "R-HSA-442755", "name": "Activation of NMDA receptors and postsynaptic events"}, {"id": "R-HSA-445717", "name": "Aquaporin-mediated transport"}, {"id": "R-HSA-453274", "name": "Mitotic G2-G2/M phases"}, {"id": "R-HSA-5358351", "name": "Signaling by Hedgehog"}, {"id": "R-HSA-5610787", "name": "Hedgehog 'off' state"}, {"id": "R-HSA-5617833", "name": "Cilium Assembly"}, {"id": "R-HSA-5620912", "name": "Anchoring of the basal body to the plasma membrane"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-68877", "name": "Mitotic Prometaphase"}, {"id": "R-HSA-68886", "name": "M Phase"}, {"id": "R-HSA-69275", "name": "G2/M Transition"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-8854518", "name": "AURKA Activation by TPX2"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9634597", "name": "GPER1 signaling"}, {"id": "R-HSA-9658195", "name": "Leishmania infection"}, {"id": "R-HSA-9660821", "name": "ADORA2B mediated anti-inflammatory cytokines production"}, {"id": "R-HSA-9662851", "name": "Anti-inflammatory response favouring Leishmania parasite infection"}, {"id": "R-HSA-9664323", "name": "FCGR3A-mediated IL10 synthesis"}, {"id": "R-HSA-9664433", "name": "Leishmania parasite growth and survival"}, {"id": "R-HSA-9824443", "name": "Parasitic Infection Pathways"}, {"id": "R-HSA-983231", "name": "Factors involved in megakaryocyte development and platelet production"}], "wikipathways": [{"id": "WP289", "name": "Myometrial relaxation and contraction pathways"}, {"id": "WP35", "name": "G Protein Signaling Pathways"}, {"id": "WP3869", "name": "Cannabinoid receptor signaling"}, {"id": "WP3965", "name": "Lipid Metabolism Pathway"}, {"id": "WP4540", "name": "Pathways Regulating Hippo Signaling"}, {"id": "WP4541", "name": "Hippo-Merlin Signaling Dysregulation"}, {"id": "WP536", "name": "Calcium Regulation in the Cardiac Cell"}, {"id": "WP706", "name": "Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways"}]}, "pfam": ["PF00027", "PF02197"], "pharmgkb": "PA33758", "pharos": {"target_id": 15382, "tdl": "Tchem"}, "pir": "A40915", "prosite": "PS50042", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF254743", "relationship": "is"}, {"id": "GNF254744", "relationship": "is"}, {"id": "GNF254745", "relationship": "is"}, {"id": "GNF254746", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF034880", "relationship": "weakly similar to"}, "GNF_mm+hs-MGC": {"id": "GNF011696", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF335901", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF098302", "relationship": "is"}, {"id": "GNF137957", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000007.14", "NC_060931.1", "NW_017852930.1"], "protein": "NP_002727.2", "rna": "NM_002736.3", "translation": {"protein": "NP_002727.2", "rna": "NM_002736.3"}}, "reporter": {"HG-U133_Plus_2": "203680_at", "HG-U95Av2": "37221_at", "HTA-2_0": "TC07000688.hg.1", "HuEx-1_0": "3018375", "HuGene-1_1": "8135378", "HuGene-2_1": "17050154"}, "summary": "cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. This subunit has been shown to interact with and suppress the transcriptional activity of the cAMP responsive element binding protein 1 (CREB1) in activated T cells. Knockout studies in mice suggest that this subunit may play an important role in regulating energy balance and adiposity. The studies also suggest that this subunit may mediate the gene induction and cataleptic behavior induced by haloperidol. [provided by RefSeq, Jul 2008].", "symbol": "PRKAR2B", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1418911"}, "unigene": "Hs.433068", "uniprot": {"Swiss-Prot": "P31323", "TrEMBL": ["A0A9L9PXN2", "B3KY43"]}, "wikipedia": {"url_stub": "PRKAR2B"}}